What are Biologics and why are they important? What differentiates our office from any others around the area?
Biologics are targeted therapies, composed from a variety of natural sources - human, animal, or microorganism - and may be produced by biotechnology methods and other technologies. These targeted therapies may be used to treat a variety of medical conditions for which no other treatments are available, or other therapies were tried and failed. Biologics can be administered as a subcutaneous injection, infusion or intravenous infusion.
What is Xolair?
Xolair is a subcutaneous injection therapy for patients 6 and older with moderate to severe allergic asthma, for patients 12 and older with Chronic Idiopathic Urticaria and for patients 18 and older with Chronic Rhinosinusitis with Nasal Polyps. Xolair is not used to treat sudden breathing problems. Xolair is given in 1 or more injections every 2 or 4 weeks. Please see "Biologic Cost Sheet" for more information on the cost for your prescribed biologic medication.
Nucala subcutaneous injection therapy for patients 6 and older with severe eosinophilic asthma and Chronic Rhinosinusitis with Nasal Poylps dosed at 1 injection 100mg every 4 weeks or EGPA (Eosinophilic granulomatosis with polyangiitis) dosed at 300mg every 4 weeks. Nucala is not used to treat sudden breathing problems.
Fasenra subcutaneous injection therapy for patients 12 and older with severe eosinophilic asthma. Fasenra is not used to treat sudden breathing problems. Fasenra is given in one 30 mg subcutaneous injection once every 4 weeks for 3 doses, then every 8 weeks. Eosinophilic asthma is a rare type of asthma. It’s often severe and usually comes on in adults. The main treatment for asthma are inhaled corticosteroids which don’t have much of an effect on it, even in high doses. That means it's harder to manage and you’re more likely to have asthma attacks. Usually, you need to take corticosteroid pills, which can have more side effects than an inhaler. Several biologics are approved to reduce the frequency of eosinophilic asthma attacks and Fasenra is one of them. Please see "Biologic Cost Sheet" for more information on the cost for your prescribed biologic medication.
Dupixent is a subcutaneous injection therapy for treatment of the following conditions as may be applicable: moderate to severe eczema (also known as Atopic Dermatitis ages 12 years old and up) dosed at a loading dose of either 600mg or 400mg on day 1 then 300mg or 200mg every 2 weeks thereafter, and/or Moderate/Severe Uncontrolled Asthma (ages 12 years old and up) dosed at a loading dose of either 600mg or 400mg on day 1 then 300mg or 200mg every 2 weeks thereafter, and/or Chronic Rinosinusitis with Nasal Polyposis (ages 18 years old and up) dose at either 300mg or 200mg every 2 weeks. This medication may be self-administered at home after the first (loading if applicable) dose is administered in the physician’s office for proper injection training.